bpc 157 and parkinson's Heal or Harm: Body Protective Compound-157 in the Gray Zone BPC-157 Research Peptide | 10mg

Active cancer or history of malignancy Pregnancy or breastfeeding Known peptide allergies Athletes subject to anti-doping testing (WADA prohibited) Raynauds disease or phenomenon Cold urticaria (hives from cold) Uncontrolled hypertension Peripheral vascular disease Open wounds (for local application) Pregnancy Cardiovascular conditions Diabetes (especially with neuropathy) Current infections Immunosuppression Blood clotting disorders Quality control issues represent perhaps the greatest practical risk with BPC-157

Some users report headaches associated with nasal peptide administration

CurrPharm Des 26 (25), 29712981

Anti-Doping Agency warns that there is a concerning lack of published clinical trial data because studies appear to have been cancelled or stopped without any published conclusions

Studies of supplement and peptide markets have found contamination rates of 12 to 58 percent in various product categories